CN114736222A - 一种稀土基配合物抗菌剂及其制备方法 - Google Patents
一种稀土基配合物抗菌剂及其制备方法 Download PDFInfo
- Publication number
- CN114736222A CN114736222A CN202210327842.2A CN202210327842A CN114736222A CN 114736222 A CN114736222 A CN 114736222A CN 202210327842 A CN202210327842 A CN 202210327842A CN 114736222 A CN114736222 A CN 114736222A
- Authority
- CN
- China
- Prior art keywords
- rare earth
- active compound
- earth salt
- pyridine ligand
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229910052761 rare earth metal Inorganic materials 0.000 title claims abstract description 78
- 150000002910 rare earth metals Chemical class 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 239000003242 anti bacterial agent Substances 0.000 title abstract description 19
- 150000001875 compounds Chemical class 0.000 claims abstract description 25
- 239000000463 material Substances 0.000 claims abstract description 12
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 50
- -1 rare earth salt Chemical class 0.000 claims description 33
- 239000003446 ligand Substances 0.000 claims description 26
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- 239000000243 solution Substances 0.000 claims description 14
- 229910052746 lanthanum Inorganic materials 0.000 claims description 13
- FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical group [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 claims description 13
- 238000003756 stirring Methods 0.000 claims description 13
- 239000004480 active ingredient Substances 0.000 claims description 11
- 238000001035 drying Methods 0.000 claims description 11
- 239000012266 salt solution Substances 0.000 claims description 11
- 239000004599 antimicrobial Substances 0.000 claims description 9
- 229910052684 Cerium Inorganic materials 0.000 claims description 8
- 229910052692 Dysprosium Inorganic materials 0.000 claims description 8
- 229910052691 Erbium Inorganic materials 0.000 claims description 8
- 229910052693 Europium Inorganic materials 0.000 claims description 8
- 229910052688 Gadolinium Inorganic materials 0.000 claims description 8
- 229910052689 Holmium Inorganic materials 0.000 claims description 8
- 229910052765 Lutetium Inorganic materials 0.000 claims description 8
- 229910052779 Neodymium Inorganic materials 0.000 claims description 8
- 229910052777 Praseodymium Inorganic materials 0.000 claims description 8
- 229910052773 Promethium Inorganic materials 0.000 claims description 8
- 229910052772 Samarium Inorganic materials 0.000 claims description 8
- 229910052771 Terbium Inorganic materials 0.000 claims description 8
- 229910052775 Thulium Inorganic materials 0.000 claims description 8
- 229910052769 Ytterbium Inorganic materials 0.000 claims description 8
- ZMIGMASIKSOYAM-UHFFFAOYSA-N cerium Chemical compound [Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce] ZMIGMASIKSOYAM-UHFFFAOYSA-N 0.000 claims description 8
- KBQHZAAAGSGFKK-UHFFFAOYSA-N dysprosium atom Chemical compound [Dy] KBQHZAAAGSGFKK-UHFFFAOYSA-N 0.000 claims description 8
- UYAHIZSMUZPPFV-UHFFFAOYSA-N erbium Chemical compound [Er] UYAHIZSMUZPPFV-UHFFFAOYSA-N 0.000 claims description 8
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 claims description 8
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 claims description 8
- KJZYNXUDTRRSPN-UHFFFAOYSA-N holmium atom Chemical compound [Ho] KJZYNXUDTRRSPN-UHFFFAOYSA-N 0.000 claims description 8
- OHSVLFRHMCKCQY-UHFFFAOYSA-N lutetium atom Chemical compound [Lu] OHSVLFRHMCKCQY-UHFFFAOYSA-N 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- QEFYFXOXNSNQGX-UHFFFAOYSA-N neodymium atom Chemical compound [Nd] QEFYFXOXNSNQGX-UHFFFAOYSA-N 0.000 claims description 8
- PUDIUYLPXJFUGB-UHFFFAOYSA-N praseodymium atom Chemical compound [Pr] PUDIUYLPXJFUGB-UHFFFAOYSA-N 0.000 claims description 8
- VQMWBBYLQSCNPO-UHFFFAOYSA-N promethium atom Chemical compound [Pm] VQMWBBYLQSCNPO-UHFFFAOYSA-N 0.000 claims description 8
- KZUNJOHGWZRPMI-UHFFFAOYSA-N samarium atom Chemical compound [Sm] KZUNJOHGWZRPMI-UHFFFAOYSA-N 0.000 claims description 8
- 229910052706 scandium Inorganic materials 0.000 claims description 8
- SIXSYDAISGFNSX-UHFFFAOYSA-N scandium atom Chemical compound [Sc] SIXSYDAISGFNSX-UHFFFAOYSA-N 0.000 claims description 8
- GZCRRIHWUXGPOV-UHFFFAOYSA-N terbium atom Chemical compound [Tb] GZCRRIHWUXGPOV-UHFFFAOYSA-N 0.000 claims description 8
- NAWDYIZEMPQZHO-UHFFFAOYSA-N ytterbium Chemical compound [Yb] NAWDYIZEMPQZHO-UHFFFAOYSA-N 0.000 claims description 8
- 229910052727 yttrium Inorganic materials 0.000 claims description 8
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 claims description 8
- 238000000227 grinding Methods 0.000 claims description 7
- 239000002244 precipitate Substances 0.000 claims description 7
- XNRNJIIJLOFJEK-UHFFFAOYSA-N sodium;1-oxidopyridine-2-thione Chemical compound [Na+].[O-]N1C=CC=CC1=S XNRNJIIJLOFJEK-UHFFFAOYSA-N 0.000 claims description 7
- 239000008367 deionised water Substances 0.000 claims description 6
- 229910021641 deionized water Inorganic materials 0.000 claims description 6
- 229940043810 zinc pyrithione Drugs 0.000 claims description 6
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 claims description 6
- ZHDBTKPXEJDTTQ-UHFFFAOYSA-N dipyrithione Chemical compound [O-][N+]1=CC=CC=C1SSC1=CC=CC=[N+]1[O-] ZHDBTKPXEJDTTQ-UHFFFAOYSA-N 0.000 claims description 5
- 229960003811 pyrithione disulfide Drugs 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 229910017604 nitric acid Inorganic materials 0.000 claims 2
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 16
- 239000000126 substance Substances 0.000 abstract description 4
- 239000000853 adhesive Substances 0.000 abstract description 2
- 230000001070 adhesive effect Effects 0.000 abstract description 2
- 238000010276 construction Methods 0.000 abstract description 2
- 239000000835 fiber Substances 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 231100000956 nontoxicity Toxicity 0.000 abstract description 2
- 239000003973 paint Substances 0.000 abstract description 2
- 239000004033 plastic Substances 0.000 abstract description 2
- 239000005060 rubber Substances 0.000 abstract description 2
- 238000001228 spectrum Methods 0.000 abstract description 2
- 230000005764 inhibitory process Effects 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- 230000003385 bacteriostatic effect Effects 0.000 description 5
- 238000002329 infrared spectrum Methods 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 238000007789 sealing Methods 0.000 description 5
- SMQUZDBALVYZAC-UHFFFAOYSA-N salicylaldehyde Chemical compound OC1=CC=CC=C1C=O SMQUZDBALVYZAC-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 239000002262 Schiff base Substances 0.000 description 2
- 150000004753 Schiff bases Chemical class 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- VYLVYHXQOHJDJL-UHFFFAOYSA-K cerium trichloride Chemical compound Cl[Ce](Cl)Cl VYLVYHXQOHJDJL-UHFFFAOYSA-K 0.000 description 2
- GAGGCOKRLXYWIV-UHFFFAOYSA-N europium(3+);trinitrate Chemical compound [Eu+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O GAGGCOKRLXYWIV-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- FYDKNKUEBJQCCN-UHFFFAOYSA-N lanthanum(3+);trinitrate Chemical compound [La+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O FYDKNKUEBJQCCN-UHFFFAOYSA-N 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- RSEBUVRVKCANEP-UHFFFAOYSA-N 2-pyrroline Chemical compound C1CC=CN1 RSEBUVRVKCANEP-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000005701 Calcium-Binding Proteins Human genes 0.000 description 1
- 108010045403 Calcium-Binding Proteins Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- HSJPMRKMPBAUAU-UHFFFAOYSA-N cerium(3+);trinitrate Chemical compound [Ce+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O HSJPMRKMPBAUAU-UHFFFAOYSA-N 0.000 description 1
- 239000011365 complex material Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- MWFSXYMZCVAQCC-UHFFFAOYSA-N gadolinium(iii) nitrate Chemical compound [Gd+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O MWFSXYMZCVAQCC-UHFFFAOYSA-N 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000007709 intracellular calcium signaling Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000013110 organic ligand Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- ZVJHJDDKYZXRJI-UHFFFAOYSA-N pyrroline Natural products C1CC=NC1 ZVJHJDDKYZXRJI-UHFFFAOYSA-N 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- MOODSJOROWROTO-UHFFFAOYSA-N salicylsulfuric acid Chemical compound OC(=O)C1=CC=CC=C1OS(O)(=O)=O MOODSJOROWROTO-UHFFFAOYSA-N 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940071103 sulfosalicylate Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N55/00—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur
- A01N55/02—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur containing metal atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
技术领域
本发明属于抗菌剂技术领域,具体涉及一种稀土基配合物抗菌剂及其制备方法。
背景技术
随着生活水平的提高,人们对抗菌剂的重视程度越来越高,各国科研人员对抗菌剂的研究更加深入和多元化,广谱性、高效性、环保型、低毒性抗菌剂成为研究的方向和重点。
由于稀土离子和Ca2+离子半径接近,化学性质相似,稀土离子与Ca2+的离,均属硬酸,对不同配位数的配位空间都具有较大的适应性,所以稀土可以结合在钙结合蛋白或钙依赖蛋白的结合位点上,从而干预Ca2+所介导的信号转导过程,诱导和影响细胞内钙信号;可见,稀土离子具有抑制细胞新陈代谢活动,因此,现已作为各种抑菌剂杀菌剂以及抗癌药物被广泛研究和应用。
但是,稀土离子毒性低,低浓度下其抑菌抗菌能力有限,达不到实际应用要求;人们发现将稀土离子与有机配体形成配合物,其抑菌抗菌效果明显,并且申请了相关的发明专利。如CN 101041666A公开了一种抗菌稀土三元配合物及其制备方法和应,其中将稀土离子与席夫碱水杨醛缩苯丙氨酸或席夫碱水杨醛缩天冬氨酸、邻菲咯啉配位生成三元配合物,并采用无水乙醇溶剂法制备,所制备的配合物对大肠杆菌的MIC结果为30ppm~65ppm,对金黄色葡萄球菌的MIC结果为100ppm~300ppm。CN 111205312 A公开了一种抗菌稀土配合物材料以及制备方法,采用无水乙醇溶剂法,将A硬脂酸根、B为磺基水杨酸根与稀土盐配位生产一种抗菌配合物,该配合物同时添加一定量Ag可以增强抗菌效果。以上现有技术所涉及配合物均为稀土与有机酸或咯啉配位,以有机溶剂无水乙醇为反应介质。
发明内容
本发明目的在于提供一种稀土基配合物抗菌剂。
本发明的另一目的在于提供上述稀土基配合物抗菌剂的制备方法。
本发明的技术方案如下:
一种稀土基配合物抗菌剂,其有效成分包括第一活性化合物和第二活性化合物中的至少一种,
第一活性化合物的结构式为其由吡啶类配体和可溶性稀土盐配位构成,其中,Re选自镧、铈、镨、钕、钷、钐、铕、钆、铽、镝、钬、铒、铥、镱、镥、钇和钪,该吡啶类配体由双吡啶硫酮和吡啶硫酮钠/吡啶硫酮锌以1∶1的摩尔比组成;
在本发明的一个优选实施方案中,其有效成分为所述第一活性化合物。
在本发明的一个优选实施方案中,其有效成分为所述第二活性化合物。
在本发明的一个优选实施方案中,其有效成分为所述第一活性化合物和所述第二活性化合物。
在本发明的一个优选实施方案中,所述第一活性化合物中的可溶性稀土盐选自硝酸稀土盐和氯化稀土盐,所述第二活性化合物中的可溶性稀土盐选自硝酸稀土盐和氯化稀土盐。
进一步优选的,所述硝酸稀土盐中的稀土元素选自镧、铈、镨、钕、钷、钐、铕、钆、铽、镝、钬、铒、铥、镱、镥、钇和钪。
进一步优选的,所述氯化稀土盐中的稀土元素选自镧、铈、镨、钕、钷、钐、铕、钆、铽、镝、钬、铒、铥、镱、镥、钇和钪。
上述稀土配合物抗菌剂的制备方法,包括如下步骤:
(1)将可溶性稀土盐与水混合,获得稀土盐溶液;
(2)将吡啶类配体与水混合,加热至48-52℃,然后加入氢氧化钠,搅拌溶解获得吡啶类配体溶液;
(3)边搅拌,边将上述吡啶类配体溶液滴加入上述稀土盐溶液中,滴加时间为5-20min,滴加完毕后继续搅拌20-40min;
(4)将步骤(3)所得的物料进行离心,获得沉淀,将该沉淀用去离子水离心洗涤,然后烘干;
(5)将步骤(4)所得的物料研磨至粒径50-200nm,即得。
在本发明的一个优选实施方案中,所述可溶性稀土盐和吡啶类配体的质量比为1∶5-7。
在本发明的一个优选实施方案中,所述步骤(1)中,可溶性稀土盐与水的质量比为1∶9;所述步骤(2)中,吡啶类配体与水的质量比为5-7∶13-15。
本发明的有益效果是:
1、本发明具有抗菌广谱、抗菌能力强、稳定性好和对人体无毒的特点。
2、本发明的制备方法生产工艺简单、施工简便、应用广泛,可应用于涂料、塑料、橡胶、胶粘剂、纤维、日化品等材料中。
附图说明
图1为本发明实施例1中的镧三元配合物的红外图谱。
图2为本发明实施例3中的镧三元配合物的红外图谱。
具体实施方式
以下通过具体实施方式结合附图对本发明的技术方案进行进一步的说明和描述。
实施例1
(1)稀土盐溶液的制备:称取10g稀土盐硝酸铈和硝酸镧(摩尔比2∶1),加入90g的水中,搅拌溶解,备用。
(2)吡啶类配体溶液的制备:称取50g吡啶硫酮钠和双吡啶硫酮(摩尔比1∶1),加入150g的水中,加热至50℃,然后加入适量的氢氧化钠,搅拌溶解,备用。
(3)在搅拌条件下,将步骤(1)所得的稀土盐溶液滴加入步骤(2)所得的吡啶类配体溶液中,滴加时间约20min,滴加完成后继续搅拌40min。
(4)将步骤(3)所得的物料过滤;并用去离子水清洗4次,重复离心操作;最后,取出沉淀物,在105℃烘箱中干燥5h,获得产率为93.1%的稀土配合物抗菌剂(其有效成分镧三元配合物的红外图谱如图1所示)。
(5)干燥后,将粉料进行研磨,研磨至10~200nm,密封,阴凉处保存。
实施例2
(1)稀土盐溶液的制备:称取10g稀土盐硝酸镧和硝酸钆(摩尔比6∶1),加入90g的水中,搅拌溶解,备用。
(2)吡啶类配体溶液的制备:称取60g吡啶硫酮锌和双吡啶硫酮(摩尔比1∶1)配体,加入140g的水中,加热至50℃,然后加入适量的氢氧化钠,搅拌溶解,备用。
(3)在搅拌条件下,将步骤(1)所得的稀土盐溶液滴加入步骤(2)所得的吡啶类配体溶液中,滴加时间约10min,滴加完成后继续搅拌30min。
(4)将步骤(3)所得的物料导入离心管中,进行离心操作,倒去上清液;并用去离子水清洗3次,重复离心操作;最后,取出沉淀物,在105℃烘箱中干燥6h,获得产率为93%的稀土配合物抗菌剂,其有效成分镧三元配合物的红外图谱与实施例1基本一样。
(5)干燥后,将粉料进行研磨,研磨至10~200nm,密封,阴凉处保存。
实施例3
(1)稀土盐溶液的制备:称取10g稀土盐氯化铈和硝酸铕(摩尔比3∶1),加入90g的水中,搅拌溶解,备用。
(2)吡啶类配体溶液的制备:称取70g吡啶硫酮钠和吡啶硫酮锌(摩尔比1∶1),加入130g的水中,加热至50℃,然后加入适量的氢氧化钠,搅拌溶解,备用。
(3)在搅拌条件下,将步骤(1)所得的稀土盐溶液滴加入步骤(2)所得的吡啶类配体溶液中,滴加时间约5min,滴加完成后继续搅拌20min。
(4)将步骤(3)所得的物料导入离心管中,进行离心操作,倒去上清液;并用去离子水清洗5次,重复离心操作;最后,取出沉淀物,在105℃烘箱中干燥3h,获得产率为93.6%的稀土配合物抗菌剂(其有效成分镧三元配合物的红外图谱如图2所示)。
(5)干燥后,将粉料进行研磨,研磨至10~200nm,密封,阴凉处保存。
对比例1
(1)吡啶类配体溶液的制备:称取40g吡啶硫酮钠和双吡啶硫酮(摩尔比1∶1),加入160g的水中,加热至50℃,然后加入适量的氢氧化钠,搅拌溶解,备用。
(2)用0.1molml-1稀盐酸滴定(2)溶液中,调节PH值为6~7。
(3)将步骤(3)所得的物料放入105℃烘箱中,干燥3h。
(4)干燥后,将粉料进行研磨,研磨至10~200nm,密封,阴凉处保存。
对比例2
(1)稀土盐溶液的制备:称取10g氯化铈和硝酸铕(摩尔比3∶1),加入90g的水中,搅拌溶解,然后,放入105℃烘箱中,干燥3h。
(2)干燥后,将粉料进行研磨,研磨至10~200nm,密封,阴凉处保存。
实施例和对比例所得的产品采用培养基扩散法测试评估:
培养基扩散法原理:利用抗菌剂不断溶解经琼脂扩散形成不同浓度梯度,以显示其抗菌作用。
操作步骤:将本发明实施例制备的稀土配合物抗菌剂和对比例制得的对比样品用去离子水溶解,配制成0.005mol/L的溶液,分别试验对大肠杆菌和金黄葡萄球菌的抑菌作用。采用培养基扩散法,在37℃培养箱中经18-24h培养后,用游标卡尺测定其抑菌圈直径。
抑菌圈结果评判规定和抗菌性能评价:进行平行3次重复实验,抗菌剂样品片均有抑菌效果的,判为合格;否则实验无效。根据《中华人民共和国化工行业标准》,通过抑菌圈直径大小来判断抗菌剂能力。抑菌圈直径小于或等于7mm者,判为无抑菌作用;抑菌圈直径大于7mm者,有弱抑菌作用;抑菌圈在10-20mm者,有中等抑菌作用;抑菌圈直径大于20mm者,有强抑菌作用。
表1实施例及对比例的抑菌效果
以上所述,仅为本发明的较佳实施例而已,故不能依此限定本发明实施的范围,即依本发明专利范围及说明书内容所作的等效变化与修饰,皆应仍属本发明涵盖的范围内。
Claims (10)
2.如权利要求1所述的一种稀土基配合物抗菌剂,其特征在于:其有效成分为所述第一活性化合物。
3.如权利要求1所述的一种稀土基配合物抗菌剂,其特征在于:其有效成分为所述第二活性化合物。
4.如权利要求1所述的一种稀土基配合物抗菌剂,其特征在于:其有效成分为所述第一活性化合物和所述第二活性化合物。
5.如权利要求1至4中任一权利要求所述的一种稀土基配合物抗菌剂,其特征在于:所述第一活性化合物中的可溶性稀土盐选自硝酸稀土盐和氯化稀土盐,所述第二活性化合物中的可溶性稀土盐选自硝酸稀土盐和氯化稀土盐。
6.如权利要求5所述的一种稀土基配合物抗菌剂,其特征在于:所述硝酸稀土盐中的稀土元素选自镧、铈、镨、钕、钷、钐、铕、钆、铽、镝、钬、铒、铥、镱、镥、钇和钪。
7.如权利要求5所述的一种稀土基配合物抗菌剂,其特征在于:所述氯化稀土盐中的稀土元素选自镧、铈、镨、钕、钷、钐、铕、钆、铽、镝、钬、铒、铥、镱、镥、钇和钪。
8.权利要求1至7中任一权利要求所述的稀土配合物抗菌剂的制备方法,其特征在于:包括如下步骤:
(1)将可溶性稀土盐与水混合,获得稀土盐溶液;
(2)将吡啶类类配体与水混合,加热至48-52℃,然后加入氢氧化钠,搅拌溶解获得吡啶类类配体溶液;
(3)边搅拌,边将上述吡啶类类配体溶液滴加入上述稀土盐溶液中,滴加时间为5-20min,滴加完毕后继续搅拌20-40min;
(4)将步骤(3)所得的物料进行离心,获得沉淀,将该沉淀用去离子水离心洗涤,然后烘干;
(5)将步骤(4)所得的物料研磨至粒径50-200nm,即得。
9.如权利要求8所述的制备方法,其特征在于:所述可溶性稀土盐和吡啶类类配体的质量比为1∶5-7。
10.如权利要求8所述的制备方法,其特征在于:所述步骤(1)中,可溶性稀土盐与水的质量比为1∶9;所述步骤(2)中,吡啶类配体与水的质量比为5-7∶13-15。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210327842.2A CN114736222A (zh) | 2022-03-30 | 2022-03-30 | 一种稀土基配合物抗菌剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210327842.2A CN114736222A (zh) | 2022-03-30 | 2022-03-30 | 一种稀土基配合物抗菌剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114736222A true CN114736222A (zh) | 2022-07-12 |
Family
ID=82278822
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210327842.2A Pending CN114736222A (zh) | 2022-03-30 | 2022-03-30 | 一种稀土基配合物抗菌剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114736222A (zh) |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1175574A (en) * | 1966-03-21 | 1969-12-23 | Rostone Corp | Arc-Interrupting Materials and apparatus |
US4137311A (en) * | 1977-09-22 | 1979-01-30 | William H. Rorer, Inc. | Synergistic compositions and method of use |
US5753600A (en) * | 1989-10-09 | 1998-05-19 | Kao Corporation | Liquid detergent composition |
FR2795955A1 (fr) * | 1999-07-09 | 2001-01-12 | Oreal | Compositions cosmetiques contenant un fructane cationique et un agent antipelliculaire et leurs utilisations |
CN100998335A (zh) * | 2006-12-29 | 2007-07-18 | 上海师范大学 | 一种核壳结构的稀土纳米抗菌剂及其制备方法和应用 |
CN101456875A (zh) * | 2008-10-31 | 2009-06-17 | 上海华明高技术(集团)有限公司 | 氢键型稀土金属配合物及其制备方法 |
CN101723962A (zh) * | 2008-10-31 | 2010-06-09 | 华东理工大学 | 吡啶二甲酸稀土简单配合物及其制备方法 |
WO2010114493A1 (en) * | 2009-04-01 | 2010-10-07 | Agency For Science, Technology And Research | Lanthanide metal complexes useful in treating cancer |
JP2017043559A (ja) * | 2015-08-27 | 2017-03-02 | 住化エンバイロメンタルサイエンス株式会社 | 抗菌剤組成物 |
WO2019188353A1 (ja) * | 2018-03-29 | 2019-10-03 | 富士フイルム株式会社 | 抗菌性組成物、抗菌膜、抗菌膜付き基材 |
CN115073499A (zh) * | 2022-06-21 | 2022-09-20 | 厦门稀土材料研究所 | 一种抗菌性稀土化合物及其应用 |
CN115197247A (zh) * | 2022-07-15 | 2022-10-18 | 太原师范学院 | 一种具有广谱抗菌稀土配合物及其制备方法和应用 |
-
2022
- 2022-03-30 CN CN202210327842.2A patent/CN114736222A/zh active Pending
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1175574A (en) * | 1966-03-21 | 1969-12-23 | Rostone Corp | Arc-Interrupting Materials and apparatus |
US4137311A (en) * | 1977-09-22 | 1979-01-30 | William H. Rorer, Inc. | Synergistic compositions and method of use |
US5753600A (en) * | 1989-10-09 | 1998-05-19 | Kao Corporation | Liquid detergent composition |
FR2795955A1 (fr) * | 1999-07-09 | 2001-01-12 | Oreal | Compositions cosmetiques contenant un fructane cationique et un agent antipelliculaire et leurs utilisations |
CN100998335A (zh) * | 2006-12-29 | 2007-07-18 | 上海师范大学 | 一种核壳结构的稀土纳米抗菌剂及其制备方法和应用 |
CN101456875A (zh) * | 2008-10-31 | 2009-06-17 | 上海华明高技术(集团)有限公司 | 氢键型稀土金属配合物及其制备方法 |
CN101723962A (zh) * | 2008-10-31 | 2010-06-09 | 华东理工大学 | 吡啶二甲酸稀土简单配合物及其制备方法 |
WO2010114493A1 (en) * | 2009-04-01 | 2010-10-07 | Agency For Science, Technology And Research | Lanthanide metal complexes useful in treating cancer |
JP2017043559A (ja) * | 2015-08-27 | 2017-03-02 | 住化エンバイロメンタルサイエンス株式会社 | 抗菌剤組成物 |
WO2019188353A1 (ja) * | 2018-03-29 | 2019-10-03 | 富士フイルム株式会社 | 抗菌性組成物、抗菌膜、抗菌膜付き基材 |
CN115073499A (zh) * | 2022-06-21 | 2022-09-20 | 厦门稀土材料研究所 | 一种抗菌性稀土化合物及其应用 |
CN115197247A (zh) * | 2022-07-15 | 2022-10-18 | 太原师范学院 | 一种具有广谱抗菌稀土配合物及其制备方法和应用 |
Non-Patent Citations (3)
Title |
---|
ZACHARY K. HUFFMAN ET AL.: "Synthesis and characterization of a bimetallic americium(III) pyrithionate coordination complex", 《CHEM. COMMUN.》, vol. 58, pages 11791 * |
李树安 等: "双毗陡硫酮的合成改进", 《精细石油化工》, vol. 29, no. 6, pages 55 - 57 * |
李海涛 等: "吡啶硫酮类化合物研究进展", 《上海化工》, vol. 43, no. 7, pages 43 - 48 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103975951B (zh) | 一种氧化石墨烯/银络合抗菌材料及其制备方法 | |
Nguyen et al. | Postsynthetic diazeniumdiolate formation and NO release from MOFs | |
CN102138569A (zh) | 一种稀土类复合抗菌剂及其应用 | |
Anacona et al. | Manganese (II) and palladium (II) complexes containing a new macrocyclic Schiff base ligand: antibacterial properties | |
Qian | Synthesis, Crystal Structures, and Biological Activity of Manganese (III) Complexes Derived from bis-Schiff Bases | |
CN101723962A (zh) | 吡啶二甲酸稀土简单配合物及其制备方法 | |
Salehi et al. | Synthesis and characterization of new cobalt (III) and nickel (II) complexes derived from acetylacetone and 2-aminopyridine: A new precursor for preparation of NiO nanoparticles | |
CN114736222A (zh) | 一种稀土基配合物抗菌剂及其制备方法 | |
CN109369516B (zh) | 一种Cu-Ag双金属水凝胶的制备方法与一种晶体的制备方法 | |
CN101456875A (zh) | 氢键型稀土金属配合物及其制备方法 | |
Sheikhshoaie et al. | Two new Cu (II) and Zn (II) Schiff base complexes: synthesis, characterization and their biological activity | |
CN114736221B (zh) | 一种稀土基配合物海洋防污剂及其制备方法 | |
Chiswell et al. | The multidentate chemistry of manganese (II). II. Six and eight coordinate compounds with bidentate ligands | |
CN115403767A (zh) | 一种阳离子有机聚合物的制备方法及对高铼酸根的吸附应用 | |
Gölcü et al. | Spectral, analytical, thermal, and antimicrobial studies of novel sodium 2-[4 (2-hydroxy-3-izopropylaminopropoxy) phenyl] acetamide (atenolol) dithiocarbamate and its divalent transition metal complexes | |
CN115197247A (zh) | 一种具有广谱抗菌稀土配合物及其制备方法和应用 | |
US3845014A (en) | Metal compounds of polycarbamoylamidrazones | |
CN113121004A (zh) | 去除水体中磺胺二甲基嘧啶的方法 | |
Chandraiah et al. | Kinetics of electron transfer from aliphatic amines to Ni (IV) periodate complex in aqueous alkaline medium | |
CN102584871A (zh) | 一种含席夫碱与联吡啶的稀土配合物及其制备方法与抑菌应用 | |
CN111887259A (zh) | 金属胶体活性炭抗菌剂及其制备方法、及其无机人造石 | |
Hao et al. | A new Zn (II)-containing coordination polymer for photocatalytic degradation of organic dyes and treatment activity on atherosclerosis via reducing the Vcam-1 expression | |
Brzyska et al. | Thermal decompositions of zinc (II) benzenedicarboxylates | |
Mallick et al. | Substitution of aqua ligands from cis-diaqua-bis (bipyridyl) ruthenium (II) by 1, 10-phenanthroline in aqueous medium | |
JPH04170960A (ja) | 抗菌性ハイドロキシアパタイト |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |